Pursuing the next breakthrough

A much-anticipated clinical trial testing purified CAR-T cells manufactured at Hollings has launched, with hopes of fewer side effects and longer-lasting results.

Read about the trial
a patient sitting in a hospital bed looks up at his doctor

MUSC Hollings Cancer Center

National Cancer Institute Designated Cancer Center logo

At the forefront of cancer research, MUSC Hollings Cancer Center is one of 72 National Cancer Institute-designated cancer centers in the nation and the only one in South Carolina. This research is the driving force behind delivering medical advances to patients and their families, enabling us to educate health care professionals and the public and to establish outreach services for underserved populations across the state.

The Hollings difference

a patient talks with her doctor

Our cutting-edge research translates into new and better treatments that help patients, including advanced surgical techniques and innovative clinical trials. MUSC Health University Medical Center is ranked by U.S. News & World Report as a high performing hospital for cancer care and has been awarded with Magnet Recognition®, an acknowledgment of quality patient care, nursing excellence, and innovations in professional nursing practice.

Why choose Hollings

Research drives cures

Our researchers, scientists, and clinicians collaborate to make innovative discoveries that advance cancer care forward.

Research Programs
illustration of cancer cells with bursts of light representing innovation and discovery

Why Choose Hollings

From cutting edge treatments and innovative clinical trials to leading experts and specialists in complex cancer cases, Hollings offers cancer treatment and care that can't be found anywhere else in South Carolina.

Follow us on social media for inspiring stories from our cancer survivors and the latest updates on research advances.

Facebook icon Twitter icon Instagram icon LinkedIn logo icon

Knowing you have cancer isn't as scary as having cancer but not knowing about it because you won't get screened.

Aleasa Barry, breast cancer survivor

Aleasa's story
a woman stands in a garden

One in three rectal cancers are in people under the age of 55. Whether you choose colonoscopy or stool-based testing, colorectal cancer screening should start at age 45 for most people.

Dr. Thomas Curran, colorectal cancer surgeon

Screening guidelines
a doctor in a white coat stands outside

Every year, HPV causes more than 30,000 cases of cancer in both men and women across the country. With the HPV vaccine, over 90% of those cases can be prevented.

Dr. Marvella Ford, associate director of population science and community outreach and engagement

HPV vaccination
Dr. Marvella Ford
a doctor speaks with a patient in an exam room

Finding tomorrow's cures

Clinical trials explore new ways to prevent and treat cancer. Participating in a study can give you access to treatments that might not be available elsewhere.

Learn about our studies

Upcoming Events

Check out our upcoming community, development, and research events.